Variety of qualified people: CDEC discussed the uncertainty in the amount of clients with reasonably serious to critical hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some patients who're categorized as owning gentle or reasonable illness could have a extreme bleeding phenotype, which https://deanoooml.tokka-blog.com/36065198/the-definitive-guide-to-hemgenix